{
    "2020-04-10": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "abandons",
                        "deal",
                        "TachoSil",
                        "surgical patch"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch, FTC says",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "abandons",
                        "deal",
                        "TachoSil",
                        "surgical patch",
                        "FTC"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Two Long-Term Values in Drug Stocks",
                "features": {
                    "keywords": [
                        "Long-Term",
                        "Values",
                        "Drug Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}